- Home
- IPHA vs TBI Comparison
IPHA vs TBI Comparison
Compare IPHA & TBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- TBI
- Stock Information
- Founded
- IPHA 1999
- TBI 1985
- Country
- IPHA France
- TBI United States
- Employees
- IPHA N/A
- TBI N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- TBI Professional Services
- Sector
- IPHA Health Care
- TBI Consumer Discretionary
- Exchange
- IPHA Nasdaq
- TBI Nasdaq
- Market Cap
- IPHA 160.1M
- TBI 165.9M
- IPO Year
- IPHA 2019
- TBI 1996
- Fundamental
- Price
- IPHA $2.18
- TBI $5.92
- Analyst Decision
- IPHA Hold
- TBI Buy
- Analyst Count
- IPHA 2
- TBI 1
- Target Price
- IPHA $2.00
- TBI $8.00
- AVG Volume (30 Days)
- IPHA 12.3K
- TBI 274.5K
- Earning Date
- IPHA 09-17-2025
- TBI 11-03-2025
- Dividend Yield
- IPHA N/A
- TBI N/A
- EPS Growth
- IPHA N/A
- TBI N/A
- EPS
- IPHA N/A
- TBI N/A
- Revenue
- IPHA $14,839,695.00
- TBI $1,534,863,000.00
- Revenue This Year
- IPHA $50.89
- TBI $2.21
- Revenue Next Year
- IPHA N/A
- TBI $6.18
- P/E Ratio
- IPHA N/A
- TBI N/A
- Revenue Growth
- IPHA N/A
- TBI N/A
- 52 Week Low
- IPHA $1.29
- TBI $3.45
- 52 Week High
- IPHA $3.51
- TBI $9.05
- Technical
- Relative Strength Index (RSI)
- IPHA 60.94
- TBI 52.43
- Support Level
- IPHA $2.07
- TBI $5.28
- Resistance Level
- IPHA $2.28
- TBI $5.63
- Average True Range (ATR)
- IPHA 0.09
- TBI 0.23
- MACD
- IPHA 0.01
- TBI 0.03
- Stochastic Oscillator
- IPHA 69.70
- TBI 81.88
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About TBI TrueBlue Inc.
TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.